A dual macrophage polarizer conjugate for synergistic melanoma therapy
Journal Article
Overview
publication date
- July 10, 2021
has subject area
- Animals
- Biological Factors - Cytokines
- Biological Factors - Tumor Necrosis Factor-alpha
- Biological Factors - Tumor Necrosis Factor-alpha
- Biological Therapy - Immunomodulation
- Blood Proteins - Tumor Necrosis Factor-alpha
- Cells - Macrophages
- Connective Tissue Cells - Macrophages
- Immune System - Macrophages
- Immune System Phenomena - Immunomodulation
- Mice
- Mononuclear Phagocyte System - Macrophages
- Myeloid Cells - Macrophages
- Neoplasms, Germ Cell and Embryonal - Melanoma
- Neoplasms, Nerve Tissue - Melanoma
- Nevi and Melanomas - Melanoma
- Peptides - Cytokines
- Peptides - Tumor Necrosis Factor-alpha
- Peptides - Tumor Necrosis Factor-alpha
- Proteins - Cytokines
- Proteins - Tumor Necrosis Factor-alpha
- Proteins - Tumor Necrosis Factor-alpha
- Proteins - Tumor Necrosis Factor-alpha
has restriction
- green
Date in CU Experts
- June 5, 2021 9:01 AM
Full Author List
- Sallam MA; Shields CW; Prakash S; Kim J; Pan DC; Mitragotri S
author count
- 6
citation count
- 6
published in
- Journal of Controlled Release Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0168-3659
Electronic International Standard Serial Number (EISSN)
- 1873-4995
Digital Object Identifier (DOI)
Additional Document Info
start page
- 333
end page
- 344
volume
- 335